Suppr超能文献

α亚基取代对βCys93氧化和镰状细胞血红蛋白稳定性的影响。

Effects of α subunit substitutions on the oxidation of βCys93 and the stability of sickle cell hemoglobin.

机构信息

Laboratory of Biochemistry and Vascular Biology, Center for Biologics Evaluation and Research, Food and Drug Administration (FDA), Silver Spring, Maryland, USA.

Hemoglobin Oxygen Therapeutics, Souderton, Pennsylvania, USA.

出版信息

Redox Rep. 2020 Dec;25(1):95-103. doi: 10.1080/13510002.2020.1834250.

Abstract

The β subunit substitutions, F41Y and K82D, in sickle cell hemoglobin (Hb) (βE6 V) provides significant resistance to oxidative stress by shielding βCys93 from the oxidizing ferryl heme. We evaluated the oxidative resistance of βCys93 to hydrogen peroxide (HO) in α subunit mutations in βE6 V (at both the putative and lateral contact regions) that included (1) αH20Q/βE6 V; (2) αH50Q/βE6 V; (3) αH20Q/H50Q/βE6 V; (4) αH20R/βE6 V; and (5) αH20R/H50Q/βE6 V. Estimation by mass spectrometry of irreversible oxidation of βCys93 to cysteic acid (CA) was unchanged or moderately increased in the single mutants harboring a H20Q or H50Q substitution when compared to control (βE6 V). The introduction of Arg (R) singularly or in combination with Q enhanced the pseudoperoxidative cycle by slightly decreasing the ferryl in favor of ferrous and ferric species after treatment with HO. Higher rates for heme loss from the ferric forms of the Q species to the receptor high affinity recombinant apomyglobin were observed in contrast to the R mutants and control. Because of their improved solubility, a combination of Q and R substitutions together with mutations carrying redox active variants (F41Y/K82D) may provide dual antioxidant and antisickling targets in the design of gene therapy-based candidates.

摘要

β亚基取代 F41Y 和 K82D 使镰状细胞血红蛋白 (Hb) (βE6V) 具有显著的抗氧化应激能力,可保护βCys93 免受氧化高铁血红素的影响。我们评估了在βE6V 中的α亚基突变(位于假定和侧接触区域)中βCys93 对过氧化氢 (HO) 的抗氧化能力,包括 (1) αH20Q/βE6V;(2) αH50Q/βE6V;(3) αH20Q/H50Q/βE6V;(4) αH20R/βE6V;和 (5) αH20R/H50Q/βE6V。通过质谱法估计不可逆氧化βCys93 为半胱氨酸酸 (CA) 的情况,与对照(βE6V)相比,携带 H20Q 或 H50Q 取代的单突变体没有变化或适度增加。当用 HO 处理时,Arg (R) 单一或与 Q 一起引入略微降低高铁血红素,有利于亚铁和三价物种,从而增强了假过氧化物酶循环。与 R 突变体和对照相比,观察到 Q 物种的高铁形式的血红素从受体高亲和力重组去氧血红蛋白中损失的速率更高。由于它们的溶解度提高,与具有氧化还原活性变体 (F41Y/K82D) 的突变体相结合的 Q 和 R 取代可能为基因治疗候选物的设计提供双重抗氧化和抗镰状细胞的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7192/7594797/9e88e9a3ed5c/YRER_A_1834250_F0001_OC.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验